Recent News

The type-2-diabetes has become an epidemic in Asian region. Currently available small-molecule insulanotropic therapies have found limited use because of associated hypoglycemic side-effects. Rapidly rising disease burden can be intervened by the insulanotropic compounds which can induce insulin secretion, from pancreas, only at elevated plasma glucose concentration in similar manner as GLP-1 (glucagon like peptide-1) act.

Shantani signed an agreement with India’s Department of Biotechnology and received funds under Small Business Innovation Research Initiatives (SBIRI) which will be directly utilized in identifying and validating novel targets of a small-molecule GLP-1 analogue at cellular level. After establishing the target identity Shantani plans to validate the target(s) in appropriate animal models and screen NCEs/Biologics for improved therapeutic outcomes.

07/09/2011 DSIR Recognition

In a major gain to Shantani's efforts Department of Science & Industrial Research (DSIR), Govt. of India accorded recognition to its in-house R&D unit. This recognition not only assist in gaining Custom and Central Excise Duty exemption but bench mark Shantani's efforts of developing research based technologies.

15/03/2011 Equity Investment

Shantani signed agreement with Entrepreneurship Development Center (EDC) / Venture Center (VC) to receive undisclosed amount of seed-funds in equity sharing mode to advance its chemical proteomics technology for small-molecule target identification. EDC is a fund channel partner of Technology Development Board, Department of Science and Technology, Government of India.

About Shantani - Shantani Proteome Analytics Pvt. Ltd. (Shantani) is a research based biotechnology company and leader in the use of Advanced Chemical Proteomics Technology. Shantani apply innovative technologies to identify and validate new drug targets and create path-forward solutions for life-sciences-based products.

About EDC / VC - Venture Center strives to nucleate and nurture technology and knowledge-based enterprises by leveraging the scientific and engineering competencies of the institutions in the "Pune region" in India. The Venture Center is a technology business incubator specializing in technology startups offering products and services exploiting scientific expertise in the areas of materials, chemicals and biological sciences & engineering. The Venture Center is the trademark of Entrepreneurship Development Center, a not-for-profit company hosted by the National Chemical Laboratory, Pune, India.

---